Influenzinum Pellet
Product Images NDC 0220-2728

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Influenzinum (NDC 0220-2728). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Boiron, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Influenzinum 2022 2023 9c Udt)

Label for Influenizinum 9C homeopathic medicine pellets by Boiron. The label includes the NDC 0220-2728-31, details drug facts including active ingredient and directions, manufacturer information, and warnings. It is marketed as homeopathic medicine made in France and distributed by Boiron Inc.*

FDA Label Image

Label (Influenzinum 2022 2023 9c)

Influenzinum 9C oral pellet homeopathic medicine label by Boiron. The label mentions use for after effects of flu or flu-like symptoms, contains approximately 80 pellets per package. Made in France, with NDC 0220-2728-41. Instructions include dissolving 5 pellets under the tongue 3 times daily until symptoms improve. The label also includes safety warnings and storage directions, along with a depiction of how to open and take the pellets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.